Total Payments
$7,166
2024 Payments
$486.46
Companies
47
Transactions
299
Medicare Patients
8,515
Medicare Billing
$558,684
Payment Breakdown by Category
Food & Beverage$5,592 (78.0%)
Travel$895.55 (12.5%)
Education$678.48 (9.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,592 | 287 | 78.0% |
| Travel and Lodging | $895.55 | 3 | 12.5% |
| Education | $678.48 | 9 | 9.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Astellas Pharma US Inc | $1,199 | 53 | $0 (2024) |
| Teleflex LLC | $1,052 | 9 | $0 (2023) |
| Janssen Biotech, Inc. | $588.09 | 21 | $0 (2024) |
| ABBVIE INC. | $501.63 | 38 | $0 (2024) |
| PFIZER INC. | $478.04 | 50 | $0 (2024) |
| Dendreon Pharmaceuticals LLC | $438.59 | 7 | $0 (2021) |
| PROCEPT BioRobotics Corporation | $319.33 | 4 | $0 (2024) |
| Mevion_Medical_Systems_Inc | $308.69 | 1 | $0 (2021) |
| Novartis Pharmaceuticals Corporation | $259.29 | 7 | $0 (2024) |
| Allergan, Inc. | $165.66 | 10 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $486.46 | 24 | Astellas Pharma US Inc ($139.86) |
| 2023 | $951.18 | 30 | Astellas Pharma US Inc ($281.45) |
| 2022 | $891.33 | 30 | Novartis Pharmaceuticals Corporation ($161.27) |
| 2021 | $1,860 | 44 | Teleflex LLC ($1,011) |
| 2020 | $173.01 | 10 | Astellas Pharma US Inc ($76.59) |
| 2019 | $1,223 | 49 | Astellas Pharma US Inc ($334.43) |
| 2018 | $971.29 | 58 | PFIZER INC. ($180.72) |
| 2017 | $609.64 | 54 | PFIZER INC. ($117.73) |
All Payment Transactions
299 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/02/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $13.49 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 09/11/2024 | Astellas Pharma US Inc | — | Education | In-kind items and services | $68.00 | General |
| 09/04/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $23.90 | General |
| Category: Cryoablation needles_PI | ||||||
| 08/20/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $24.62 | General |
| Category: Oncology | ||||||
| 08/13/2024 | Novartis Pharmaceuticals Corporation | PLUVICTO (Drug) | Food and Beverage | In-kind items and services | $24.86 | General |
| Category: Oncology | ||||||
| 08/06/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $21.71 | General |
| Category: ONCOLOGY | ||||||
| 07/26/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $13.54 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 07/24/2024 | ABBVIE INC. | LUPRON DEPOT (Drug) | Food and Beverage | In-kind items and services | $15.70 | General |
| Category: ENDOCRINOLOGY | ||||||
| 06/27/2024 | PROCEPT BioRobotics Corporation | AQUABEAM SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $23.03 | General |
| Category: UROLOGY | ||||||
| 06/20/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $15.12 | General |
| Category: UROLOGY | ||||||
| 06/19/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $17.30 | General |
| Category: ONCOLOGY | ||||||
| 05/16/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $16.44 | General |
| Category: UROLOGY | ||||||
| 05/14/2024 | Novartis Pharmaceuticals Corporation | PLUVICTO (Drug) | Food and Beverage | In-kind items and services | $17.54 | General |
| Category: Oncology | ||||||
| 04/18/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $14.09 | General |
| Category: UROLOGY | ||||||
| 04/02/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $23.47 | General |
| Category: Oncology | ||||||
| 03/06/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $13.45 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 02/28/2024 | ABBVIE INC. | LUPRON DEPOT (Drug) | Food and Beverage | In-kind items and services | $18.77 | General |
| Category: ENDOCRINOLOGY | ||||||
| 02/20/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $23.77 | General |
| Category: Oncology | ||||||
| 02/13/2024 | Novartis Pharmaceuticals Corporation | PLUVICTO (Drug) | Food and Beverage | In-kind items and services | $13.70 | General |
| Category: Oncology | ||||||
| 02/10/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $13.79 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 02/09/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $14.06 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 01/31/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $19.82 | General |
| Category: Oncology | ||||||
| 01/17/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $17.42 | General |
| Category: ONCOLOGY | ||||||
| 01/04/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $18.87 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 12/12/2023 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $23.65 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 20 | 1,888 | 2,898 | $302,064 | $126,249 |
| 2022 | 26 | 2,402 | 5,150 | $468,353 | $191,437 |
| 2021 | 27 | 2,248 | 3,177 | $437,787 | $143,524 |
| 2020 | 20 | 1,977 | 2,521 | $263,883 | $97,474 |
Total Patients
8,515
Total Services
13,746
Medicare Billing
$558,684
Procedure Codes
93
All Medicare Procedures & Services
93 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 449 | 682 | $135,718 | $63,412 | 46.7% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 96 | 106 | $38,796 | $19,688 | 50.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 77 | 77 | $23,947 | $9,263 | 38.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 101 | 111 | $14,874 | $7,006 | 47.1% |
| 51728 | Complex measurement of pressure of urine flow in bladder with voiding pressure studies | Office | 2023 | 22 | 22 | $9,350 | $4,426 | 47.3% |
| 76872 | Ultrasound scan of pelvic region through rectum | Office | 2023 | 39 | 39 | $9,282 | $4,093 | 44.1% |
| 55700 | Biopsy of prostate gland | Office | 2023 | 18 | 18 | $7,128 | $3,254 | 45.7% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 218 | 334 | $10,688 | $2,639 | 24.7% |
| 51797 | Insertion of device into abdomen with pressure and urine flow rate study | Office | 2023 | 22 | 22 | $6,490 | $2,625 | 40.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 191 | 219 | $5,475 | $1,840 | 33.6% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 20 | 38 | $4,560 | $1,819 | 39.9% |
| 52332 | Insertion of stent in ureter using an endoscope | Facility | 2023 | 17 | 17 | $17,220 | $1,790 | 10.4% |
| 84153 | Psa (prostate specific antigen) measurement, total | Office | 2023 | 74 | 80 | $4,000 | $1,442 | 36.0% |
| 81003 | Automated urinalysis test | Office | 2023 | 431 | 598 | $2,990 | $1,314 | 43.9% |
| 51700 | Simple bladder irrigation and/or instillation | Office | 2023 | 12 | 16 | $2,416 | $767.53 | 31.8% |
| 84403 | Testosterone (hormone) level, total | Office | 2023 | 15 | 16 | $800.00 | $404.64 | 50.6% |
| 51784 | Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | Office | 2023 | 32 | 32 | $6,880 | $350.14 | 5.1% |
| 51741 | Electronic assessment of bladder emptying | Office | 2023 | 24 | 24 | $1,190 | $61.68 | 5.2% |
| J2704 | Injection, propofol, 10 mg | Office | 2023 | 18 | 399 | $199.50 | $34.78 | 17.4% |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | Office | 2023 | 12 | 48 | $60.00 | $19.45 | 32.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 473 | 747 | $148,653 | $67,905 | 45.7% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2022 | 116 | 137 | $50,142 | $25,483 | 50.8% |
| J3490 | Unclassified drugs | Office | 2022 | 11 | 21 | $33,000 | $17,980 | 54.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 112 | 112 | $34,832 | $12,029 | 34.5% |
| 52601 | Removal of prostate gland using an electrocautery knife through urethra with control of bleeding using an endoscope | Facility | 2022 | 18 | 18 | $29,646 | $10,453 | 35.3% |
About Dr. Thomas Herrick, MD
Dr. Thomas Herrick, MD is a Urology healthcare provider based in North Kansas City, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/15/2006. The National Provider Identifier (NPI) number assigned to this provider is 1487605275.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Thomas Herrick, MD has received a total of $7,166 in payments from pharmaceutical and medical device companies, with $486.46 received in 2024. These payments were reported across 299 transactions from 47 companies. The most common payment nature is "Food and Beverage" ($5,592).
As a Medicare-enrolled provider, Herrick has provided services to 8,515 Medicare beneficiaries, totaling 13,746 services with total Medicare billing of $558,684. Data is available for 4 years (2020–2023), covering 93 distinct procedure/service records.
Ad
Practice Information
- Specialty Urology
- Other Specialties Urology
- Location North Kansas City, MO
- Active Since 05/15/2006
- Last Updated 04/12/2021
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1487605275
Products in Payments
- UroLift System (Device) $1,011
- PROVENGE (Drug) $438.59
- ERLEADA (Drug) $419.96
- MYRBETRIQ (Drug) $388.22
- PTS250 (Device) $308.69
- AQUABEAM ROBOTIC SYSTEM (Device) $296.30
- XTANDI (Drug) $229.52
- TOVIAZ (Drug) $183.58
- Myrbetriq (Drug) $172.84
- BOTOX (Biological) $169.52
- Erleada (Drug) $168.13
- LUPRON DEPOT (Drug) $167.93
- Xtandi (Drug) $160.04
- Androgel (Drug) $143.14
- XYOSTED (Drug) $137.02
- Axumin (Drug) $133.15
- GEMTESA (Drug) $106.48
- ZYTIGA (Drug) $99.00
- VIAGRA (Drug) $93.56
- XIAFLEX (Biological) $90.14
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.